INNT
TOTAL INVALIDATION PROCESSED BY THE IB
26/04/2025
Voltar para busca
Dado oficial do USPTO
NOKSIPZA
Sabia que essa marca já está registrada no Estados Unidos?
Antes de investir em nome, identidade e divulgação, valide risco de colisão e estratégia de registro para não perder tempo nem budget.
Active USPTO registrationTipo: VerbalEscritório: US
Diagnóstico de risco e oportunidade
Leitura executiva para decisão de naming, protocolo e monitoramento.
Situação USPTO
Active USPTO registration
Tipo de processo
Pedido e registro
Eventos registrados
34
Atualização mais recente
27/04/2025
Classificação
Registrada
Tipo de marca
Verbal
Classes Nice
5, 35
Data de depósito
17/01/2017
Data de registro
31/10/2017
Data de expiração
-
Ação recomendada
Execute uma análise de colidência completa e valide classes antes de qualquer protocolo ou investimento de marca.
Próximo passo
Esses são os detalhes do processo de registro. Mesmo assim, o monitoramento constante é o que garante tranquilidade de que o seu principal ativo continue protegido.
Dados completos do processo
Campos estruturados da autoridade responsável e do histórico oficial.
Data da situação
17/05/2024
Última transação
27/04/2025
Escritório responsável
United States Patent and Trademark Office
Código da situação
709
Cadastro oficial
Principal Register
Código do desenho
4
Tipo de titular
03
Localização do titular
Gyeonggi-do, KR
Examinador
MCCRAY, RENEE
Unidade examinadora
M20
Localização atual
PUBLICATION AND ISSUE SECTION
Titulares e representantes
Titulares
Green Cross Holdings Corporation
Representantes
Yoon S. Ham HAUPTMAN HAM, LLP
Classificação técnica
Classes Nice
Classe 5Classe 35
Códigos Vienna
Sem códigos Vienna disponíveis.
Produtos e serviços
Classe 5
Pharmaceutical agents affecting sensory organs; thyroid and para-thyroid hormone preparations; pharmaceutical preparations for the treatment of hormonal disorders and the prevention of osteoporosis; pharmaceutical preparations for treating diabetes; pharmaceutical agents affecting metabolism; vaccines against flu; veterinary vaccines; pharmaceutical agents affecting peripheral nervous system; pharmaceutical preparations for the treatment of the immune system by regulating it; virucides; vaccine preparations; adrenal hormone preparations; pharmaceutical preparations for use in gynecology; pharmaceutical preparations for use in urology; vitamin tablets; pharmaceutical preparations for wounds; cellular function activating agents for medical purposes; anti-inflammatory and antipyretic preparations; pharmaceutical agents affecting digestive organs; veterinary substances and preparationsantioxidants; veterinary diagnostic reagents for use in veterinary genetic testing; pharmaceutical preparations for the treatment of cardiovascular disease; ophthalmic preparations; ophthalmologic preparations; eye drops; pharmaceutical preparations for treating allergies; pharmaceutical preparations for the prevention and treatment of cancer; biological preparations for the treatment of cancer; pharmaceutical agents for epidermis; sanitary sterilising preparations; medicines for the treatment of gastrointestinal diseases; medicated mouth care and treatment preparations; parasiticides for medical use; diagnostic preparations for medical or veterinary purposes; cleansing solutions for medical use; cardiovascular agents for medical purposes; reagents for medical use; reagents for use in medical genetic testing; hemostatics for medical purposes; antibacterial substances for medical purposes; diuretics; insulin; human vaccine preparations; general anesthetics; pharmaceutical preparations for the treatment of auto-immune diseases; multivitamin preparations; pharmaceutical preparations acting on the central nervous system; styptic pencils for medical purposes; pharmaceutical preparations for treating asthma; pharmaceutical solutions used in dialysis; penicillin preparations; antimicrobials for dermatologic use; pharmaceutical preparations for treating skin disorders; contraceptive preparations; antihypertensives; anti-diabetic pharmaceuticals; antitoxins; antivirals; antiarrhythmic agents; antibiotic preparations; anti-cancer preparations; anticoagulants; tumor suppressing agents; antifungal preparations; anti-dermoinfectives; antidotes; antipyretic analgesics; vasoconstrictors; inhaled pharmaceutical preparations for the treatment of respiratory diseases and disorders; mixed antibiotic preparations; mixed hormone preparations; chemotherapeutics; pharmaceutical preparations for use in discouraging the smoking habitsmoking cessation preparations
Classe 35
Retail and wholesale store services for pharmaceuticalveterinary and sanitary preparations and medical supplies; advertising services relating to pharmaceutical products; advertising relating to pharmaceutical products and in-vivo imaging products
Publicações
Histórico de despachos e eventos da marca no USPTO.
34 publicações encontradas
INTS
TOTAL INVALIDATION OF REG EXT PROTECTION SENT TO IB
08/04/2025
INPC
INVALIDATION PROCESSED
08/04/2025
INTR
TOTAL INVALIDATION OF REG EXT PROTECTION CREATED
18/01/2025
C71T
CANCELLED SECTION 71
17/05/2024
REM3
COURTESY REMINDER - SEC. 71 (6-YR) E-MAILED
31/10/2022
FINO
FINAL DECISION TRANSACTION PROCESSED BY IB
13/04/2018
FICS
FINAL DISPOSITION NOTICE SENT TO IB
12/02/2018
FIMP
FINAL DISPOSITION PROCESSED
12/02/2018
FICR
FINAL DISPOSITION NOTICE CREATED, TO BE SENT TO IB
31/01/2018
R.PR
REGISTERED-PRINCIPAL REGISTER
31/10/2017
GPNX
NOTIFICATION PROCESSED BY IB
18/08/2017
NPUB
OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
15/08/2017
PUBO
PUBLISHED FOR OPPOSITION
15/08/2017
OPNS
NOTIFICATION OF POSSIBLE OPPOSITION SENT TO IB
02/08/2017
OP2R
NOTICE OF START OF OPPOSITION PERIOD CREATED, TO BE SENT TO IB
02/08/2017
NONP
NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
26/07/2017
PREV
LAW OFFICE PUBLICATION REVIEW COMPLETED
10/07/2017
CNSA
APPROVED FOR PUB - PRINCIPAL REGISTER
06/07/2017
TEME
TEAS/EMAIL CORRESPONDENCE ENTERED
05/07/2017
CRFA
CORRESPONDENCE RECEIVED IN LAW OFFICE
05/07/2017
ALIE
ASSIGNED TO LIE
29/06/2017
TROA
TEAS RESPONSE TO OFFICE ACTION RECEIVED
01/06/2017
ARAA
ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED
31/05/2017
REAP
TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED
31/05/2017
RFNT
REFUSAL PROCESSED BY IB
05/05/2017
RFCS
NON-FINAL ACTION MAILED - REFUSAL SENT TO IB
19/04/2017
RFRR
REFUSAL PROCESSED BY MPU
19/04/2017
MAFR
APPLICATION FILING RECEIPT MAILED
18/04/2017
RFCR
NON-FINAL ACTION (IB REFUSAL) PREPARED FOR REVIEW
16/04/2017
CNRT
NON-FINAL ACTION WRITTEN
15/04/2017
DOCK
ASSIGNED TO EXAMINER
15/04/2017
NWOS
NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
14/04/2017
REPR
SN ASSIGNED FOR SECT 66A APPL FROM IB
13/04/2017
Proteção contínua da sua marca
Seja avisado a cada novo depósito que ameace NOKSIPZA ou a sua marca.
Vigilância profissional por 24 meses: monitoramos o USPTO por você e alertamos a tempo de você se opor — antes que o conflito vire prejuízo.